William W. Ericson, Director, 10% Owner at Adamas Pharmaceuticals Inc (ADMS), sold 8,657 shares at $27.53 ($238K) on 2015-07-10, disclosed to the SEC on 2015-07-14.
Scheduled sale ($238k) by Director, 10% Owner under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| ADMS | BUY | 2016-09-16 | $2.1M | — | Filing → |
| ADMS | BUY | 2016-09-14 | $2.6M | — | Filing → |
| ADMS | BUY | 2016-09-09 | $1.9M | — | Filing → |